Ultherapy vs Morpheus8

Independent side-by-side comparison with pricing, specs, and clinical evidence.

Last updated: 2026-04-09

Why This Comparison Matters

Ultherapy and Morpheus8 sit in the same skin tightening category but take different approaches. Ultherapy (Merz Aesthetics) uses Microfocused Ultrasound with Visualization (MFU-V) while Morpheus8 (InMode) uses Fractional RF Microneedling with bipolar RF and burst mode. Both received FDA clearance (2009 and 2020 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.

Physicians end up comparing these two devices when they're shopping in the $70,000-$120,000 to $40,000-$60,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.

Side-by-Side Specifications

Ultherapy Morpheus8
Manufacturer Merz Aesthetics InMode
Technology Microfocused Ultrasound with Visualization (MFU-V) Fractional RF Microneedling with bipolar RF and burst mode
Price (New) $70,000-$120,000 $40,000-$60,000
Price (Used) $30,000-$60,000 $25,000-$45,000
Treatment Time 30-90 minutes 15-60 minutes depending on area
Sessions 1 session, maintenance every 12-18 months 1-3 sessions
Per Session $1,800-$5,000 $800-$2,500
Annual Consumables $15,000-$35,000 (transducers) $3,000-$8,000 (tips)
Annual Maintenance $4,000-$9,000 $2,000-$5,000
FDA Cleared Yes (2009) Yes (2020)

Technology

Ultherapy

Technology: Microfocused Ultrasound with Visualization (MFU-V). The only non-invasive lifting device cleared to target the SMAS layer that surgeons target in facelift surgery. Integrated imaging lets the operator see each treatment layer before delivering energy.

Morpheus8

Technology: Fractional RF Microneedling with bipolar RF and burst mode. Deepest RF microneedling penetration (up to 8mm with body tip). Subdermal fat remodeling + collagen induction.

Pricing

Ultherapy

New: $70,000-$120,000. Used: $30,000-$60,000. Per session: $1,800-$5,000. Annual consumables: $15,000-$35,000 (transducers). Annual maintenance: $4,000-$9,000.

Morpheus8

New: $40,000-$60,000. Used: $25,000-$45,000. Per session: $800-$2,500. Annual consumables: $3,000-$8,000 (tips). Annual maintenance: $2,000-$5,000.

Clinical Evidence

Ultherapy

80+ published studies. Strongest non-invasive lifting evidence base. Meta-analyses confirm measurable improvement in brow and submental laxity.

Morpheus8

50+ published studies. Strong body of evidence for facial rejuvenation. Body application evidence is growing but thinner.

Treatment Experience

Ultherapy

30-90 minutes per session. Recommended protocol: 1 session, maintenance every 12-18 months. Treatment areas: Brow, Submental (chin), Neck, Decolletage. Patients typically tolerate this platform well when operated by trained clinicians.

Morpheus8

15-60 minutes depending on area per session. Recommended protocol: 1-3 sessions. Treatment areas: Face, Neck, Body (abdomen, thighs, arms). Patient experience varies by operator training and settings.

Practice Fit

Ultherapy

Dermatology and plastic surgery practices that serve patients declining surgery but wanting measurable lift. Premium med spas with established demand for single-session skin tightening.

Morpheus8

Practices wanting the most recognized RF microneedling brand with body treatment capability. High-volume aesthetic practices where patient demand drives device selection.

Pros and Cons

Ultherapy Pros

  • Reaches the SMAS layer non-invasively (unique capability)
  • Integrated ultrasound imaging improves targeting accuracy
  • Strongest lifting claims among non-invasive devices
  • Long safety record (cleared since 2009)

Ultherapy Cons

  • Treatment can be painful and usually requires pre-medication
  • Transducer consumables are expensive and area-specific
  • Results develop gradually over 2-6 months

Morpheus8 Pros

  • Deepest penetration depth in the category (4mm face, 8mm body)
  • Strong brand recognition (highest consumer search volume in RF microneedling)
  • Body treatment capability (unique among RF microneedling platforms)
  • Can be combined with other InMode platforms (BodyTite, FaceTite)

Morpheus8 Cons

  • 14 FDA adverse events in March 2026 alone (up from 3/mo baseline)
  • 9 thermal injury reports, 3 scarring reports in recent MAUDE data
  • Consumable tip costs are significant

The Verdict

Choose Ultherapy if your practice prioritizes Merz Aesthetics's ecosystem, brand recognition, or specific clinical advantages. Dermatology and plastic surgery practices that serve patients declining surgery but wanting measurable lift. Premium med spas with established demand for single-session skin tightening. The pros that matter most: Reaches the SMAS layer non-invasively (unique capability); Integrated ultrasound imaging improves targeting accuracy. The biggest tradeoff to accept: Treatment can be painful and usually requires pre-medication.

Choose Morpheus8 if InMode's positioning fits better. Practices wanting the most recognized RF microneedling brand with body treatment capability. High-volume aesthetic practices where patient demand drives device selection. The pros that matter most: Deepest penetration depth in the category (4mm face, 8mm body); Strong brand recognition (highest consumer search volume in RF microneedling). The biggest tradeoff to accept: 14 FDA adverse events in March 2026 alone (up from 3/mo baseline).

For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Ultherapy used units run $30,000-$60,000; Morpheus8 used units run $25,000-$45,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.

Frequently Asked Questions

Which is more expensive, Ultherapy or Morpheus8?

Ultherapy runs $70,000-$120,000 new and $30,000-$60,000 used. Morpheus8 runs $40,000-$60,000 new and $25,000-$45,000 used. Per-session pricing is $1,800-$5,000 for Ultherapy and $800-$2,500 for Morpheus8. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.

Which has better clinical evidence, Ultherapy or Morpheus8?

Ultherapy clinical evidence: 80+ published studies. Strongest non-invasive lifting evidence base. Meta-analyses confirm measurable improvement in brow and submental laxity. Morpheus8 clinical evidence: 50+ published studies. Strong body of evidence for facial rejuvenation. Body application evidence is growing but thinner. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.

Is Ultherapy or Morpheus8 more popular in dermatology practices?

Both Ultherapy and Morpheus8 are commonly used in dermatology, plastic surgery, med spa practices. Market share in any given category shifts year to year. Merz Aesthetics and InMode both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.

Are there safety concerns with Ultherapy or Morpheus8?

Both devices are FDA cleared and have established safety profiles. Ultherapy has these documented concerns: Treatment can be painful and usually requires pre-medication. Morpheus8 has: 14 FDA adverse events in March 2026 alone (up from 3/mo baseline). Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.

Can I use Ultherapy and Morpheus8 in the same practice?

Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.

What's the resale value comparison between Ultherapy and Morpheus8?

Used Ultherapy sells for $30,000-$60,000 on the secondary market. Used Morpheus8 sells for $25,000-$45,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.